Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valerius Biopharma
Basel, Basel-City, Switzerland
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Valerius Biopharma is developing specialty biosimilars targeting high-priced biologics across multiple therapeutic areas. The company has four biosimilar candidates in early pre-clinical development stages, including monoclonal antibodies, enzymes, and fusion proteins. The company aims to bring one or more products to market within six years from 2018.
- Therapeutic areas
- OncologyPulmonologyImmunologyOphthalmology
- Modalities
- Monoclonal antibodyRecombinant fusion proteinRecombinant protein
- Industry
- Biotech
02
Partnerships
Catalent Biologics
Beyond the preview
Go deeper on Valerius Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Valerius Biopharma.